C&R Research Inc. (359090) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for C&R Research Inc. (359090:KRX), powered by AI.

Current Price
₩550
P/E Ratio
2.4
Market Cap
6.3B
Sector
Healthcare
What is the C&R Research Inc. stock price forecast?

C&R Research Inc. is currently trading at ₩550. View real-time AI analysis on Alpha Lenz.

What is C&R Research Inc. insider trading activity?

View the latest insider trading data for C&R Research Inc. on Alpha Lenz.

What is C&R Research Inc.'s P/E ratio?

C&R Research Inc.'s P/E ratio is 2.4.

C&R Research Inc.

KRX · 359090
₩550+0(+0.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about C&R Research Inc.'s future dividend policy...
Alpha Chat Insight

C&R Research Inc. trades at a P/E of 2.4 (undervalued) with modest ROE of 5.4%. 3Y revenue CAGR of 10.3% highlights clear growth momentum.

Ask for details

Company Overview

C&R Research Inc. is a company specializing in providing insights and analytics services focused on consumer behavior and market research. Its primary function is to deliver detailed research reports and data-driven insights to help various industries understand market trends and consumer demand. C&R Research serves sectors including retail, healthcare, financial services, and technology, offering tailored solutions that guide product development, marketing strategies, and customer engagement efforts. Through its innovative research methodologies, C&R Research Inc. plays a crucial role in informing business executives and decision-makers. The company is especially significant in the retail sector, where companies rely on its expertise to anticipate shifts in consumer preferences and behaviors. Positioned uniquely within the market research industry, C&R Research helps its clients adapt and thrive in competitive markets by providing actionable intelligence that supports strategic planning and operational enhancements.

CEO윤문태
SectorHealthcare
IndustryHealth Information Services
Employees505

Company Statistics

FY 2025

Profile

₩6,321,778,650Market Cap
₩64,982,070,920Revenue
11.49MShares Out
505Employees

Margins

100.00%Gross
3.61%EBITDA
2.13%Operating
1.54%Pre-Tax
1.57%Net

Valuation

2.45P/E
0.13P/B
0.10EV/Sales
1.33EV/EBITDA
-1.88P/FCF

Growth (CAGR)

10.26%Rev 3Yr
13.75%Rev 5Yr
-33.93%Op Inc 3Yr
-22.45%Op Inc 5Yr
-36.18%Net Inc 3Yr
-16.06%Net Inc 5Yr

Returns

1.20%ROA
5.37%ROE
1.43%ROIC

Financial Health

₩8,848,468,090Cash & Cash Equivalents
₩27,961,382,270Net Debt
76.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

C&R Research Inc. (ticker: 359090) is a company listed on KRX in the Healthcare sector (Health Information Services). It has approximately 505 employees. Market cap is $6.3B.

The current price is ₩550 with a P/E ratio of 2.45x and P/B of 0.13x.

ROE is 5.37% and operating margin is 2.13%. Annual revenue is $65.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
C&R Research Inc. (359090) Stock Forecast 2026 ₩550 — Price, Financials & Analyst Targets | Alpha Lenz